Carregant...
Potential Adiponectin Receptor Response Modifier Therapeutics
Many human diseases may benefit from adiponectin replacement therapy, but due to pharmacological disadvantages of the intact protein, druggable options focus on peptidic, and small molecule agonists of the adiponectin receptor. Peptide-based adiponectin replacement drug leads are derived from, or re...
Guardat en:
| Publicat a: | Front Endocrinol (Lausanne) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700268/ https://ncbi.nlm.nih.gov/pubmed/31456747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00539 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|